Sections |
| Title | Starting Page | Number of Pages |
|---|
| Disclosure | 2 | 1 |
| CHAPTER ONE Executive Summary | 15 | 1 |
| BACKGROUND | 15 | 1 |
| SCOPE AND METHODOLOGY | 15 | 3 |
| SIZE AND GROWTH OF THE MARKET | 17 | 2 |
| KEY ISSUES AND TRENDS AFFECTING MARKET | 22 | 1 |
| LEADING COMPETITORS | 22 | 2 |
| CHAPTER TWO Introduction | 25 | 1 |
| BACKGROUND | 25 | 1 |
| DISTRIBUTION AND SAFETY ISSUES IN THE UNITED STATES | 26 | 1 |
| CONSUMER ADVERTISING/PROMOTION | 27 | 1 |
| WORLD HEALTH AND LIFE EXPECTANCY | 28 | 8 |
| DECLINING GROWTH OF THE WORLD POPULATION | 37 | 1 |
| PRESCRIPTION VS OVER-THE-COUNTER INDUSTRY | 39 | 7 |
| ECONOMIC TRENDS | 46 | 10 |
| HEALTH INSURANCE ISSUES AND TRENDS | 55 | 1 |
| CONSUMER ISSUES AND TRENDS | 56 | 3 |
| ACCESS TO PROFESSIONAL MEDICAL SERVICES AND THE LINK TO SELF-MEDICATION | 59 | 1 |
| REGULATORY ENVIRONMENT | 59 | 4 |
| CHAPTER THREE OTC Markets in Asia-Pacific and Africa | 64 | 1 |
| OVERVIEW | 64 | 1 |
| DEMOGRAPHICS | 64 | 6 |
| OTC PRODUCT SEGMENTS | 79 | 3 |
| MARKET ANALYSIS | 83 | 14 |
| CHAPTER FOUR OTC Markets in Europe | 99 | 1 |
| OVERVIEW | 99 | 1 |
| DEMOGRAPHICS | 99 | 4 |
| OTC PRODUCT SEGMENTS | 107 | 2 |
| MARKET ANALYSIS | 110 | 14 |
| CHAPTER FIVE OTC Markets in North America | 126 | 1 |
| OVERVIEW | 126 | 1 |
| DEMOGRAPHICS | 126 | 2 |
| OTC PRODUCT SEGMENTS | 133 | 2 |
| MARKET ANALYSIS | 136 | 13 |
| CHAPTER SIX OTC Markets in South America | 151 | 1 |
| OVERVIEW | 151 | 1 |
| DEMOGRAPHICS | 151 | 2 |
| OTC PRODUCT SEGMENTS | 158 | 2 |
| MARKET ANALYSIS | 161 | 13 |
| CHAPTER SEVEN Summary of World OTC Markets | 177 | 1 |
| OVERVIEW | 177 | 12 |
| CHAPTER EIGHT Leading OTC Manufacturers | 191 | 1 |
| OVERVIEW | 191 | 1 |
| COMPETITOR ANALYSIS | 191 | 3 |
| SIGNIFICANT MERGERS AND ACQUISITIONS | 196 | 2 |
| LEADING CORPORATE PROFILES | 198 | 1 |
| BAYER HEALTHCARE AG | 199 | 1 |
| Overview | 199 | 25 |
| BOEHRINGER INGELHEIM GMBH | 201 | 1 |
| CHATTEM, INC. | 203 | 1 |
| GLAXO SMITH KLINE | 205 | 1 |
| MC NEIL CONSUMER (JOHNSON & JOHNSON) | 208 | 1 |
| NOVARTIS CONSUMER | 210 | 1 |
| PROCTER & GAMBLE | 212 | 1 |
| RECKITT BENCKISER | 213 | 1 |
| SANOFI-AVENTIS | 215 | 1 |
| SCHERING-PLOUGH | 217 | 1 |
| TAISHO PHARMACEUTICAL | 219 | 1 |
| TAKEDA PHARMACEUTICAL | 221 | 1 |
| WYETH | 222 | 1 |
| APPENDIX List of Major Companies | 224 | 2 |
Tables |
| Title | Starting Page | Number of Pages |
|---|
| 1 Total World OTC Market Analysis, 2005-2007 | 19 | 1 |
| 2 Forecasted Total World OTC Market Analysis: 2008-2012 | 20 | 1 |
| 1 Average Life Expectancy in Years by Country 1980, 2004 and Estimated 2006 | 29 | 1 |
| 2 Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010 | 31 | 1 |
| 3 Percent of Smokers by Country | 34 | 1 |
| 4 Percent of Population that is Obese (*) in 2003, 2004 and Estimated 2005 | 36 | 1 |
| 5 World Population 1980 to 2050 | 37 | 1 |
| 6 Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Region, 2007 | 40 | 1 |
| 7 Leading FDA Approved Rx-to-OTC Switches, 1994-2007 | 43 | 1 |
| 8 Potential Rx-to-OTC Switches, 2008-2013 | 45 | 2 |
| 9 Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006 | 48 | 1 |
| 10 Gross National Income Comparison by Country 2000-2005 | 51 | 1 |
| 11 National Healthcare Expenditures in the United States 1960-2010 | 53 | 1 |
| 12 Health Insurance Trends in the United States 2003-2006 | 56 | 1 |
| 1 Population by Age Group for the Five Most Populated Countries in Asia-Pacific, Estimated 2007 | 70 | 1 |
| 2 Population by Age Group for the Five Most Populated Countries in Asia-Pacific, Projected 2012 | 71 | 1 |
| 3 Population by Age Group for Africa, Estimated 2007 and 2012 | 73 | 1 |
| 4 Population by Gender for the Five Most Populated Countries in Asia-Pacific, Estimated 2007 and Projected 2012 | 75 | 1 |
| 5 Population by Gender for Africa, Estimated 2007 and Projected 2012 | 77 | 1 |
| 6 Examples of Marketed OTC Products in Asia-Pacific and Africa (Product Name by Type and Marketer) | 82 | 1 |
| 7 Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2007 and 2012 | 84 | 1 |
| 8 Asia-Pacific/Africa OTC Market Analysis, 2005-2007 | 86 | 1 |
| 9 Forecasted Asia-Pacific/Africa OTC Market Analysis: 2008-2012 | 87 | 1 |
| 10 Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2007 | 91 | 1 |
| 11 Forecasted Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2008-2012 | 92 | 1 |
| 12 Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2007 | 97 | 1 |
| 1 Population by Age for the Five Most Populated Countries in Europe, Estimated 2007 | 102 | 1 |
| 2 Population by Age for the Five Most Populated Countries in Europe, Projected 2012 | 103 | 1 |
| 3 Population by Gender for the Five Most Populated Countries in Europe, Estimated 2007 and Projected 2012 | 105 | 1 |
| 4 Examples of Marketed OTC Products in Europe (Product Name by Type and Marketer) | 109 | 1 |
| 5 European OTC Market as a Percentage of World Market, 2007 and 2012 | 111 | 1 |
| 6 European OTC Market Analysis, 2005-2007 | 113 | 1 |
| 7 Forecasted European OTC Market Analysis: 2008-2012 | 114 | 1 |
| 8 European OTC Market Analysis by Product Segment, 2005-2007 | 118 | 1 |
| 9 Forecasted European OTC Market Analysis by Product Segment, 2008-2012 | 119 | 1 |
| 10 European OTC Market Analysis by Selected Country, 2007 | 124 | 1 |
| 1 Population by Age for the Five Most Populated Countries in North America, Estimated 2007 | 128 | 1 |
| 2 Population by Age for the Five Most Populated Countries in North America, Projected 2012 | 129 | 1 |
| 3 Population by Gender for the Five Most Populated Countries in North America, Estimated 2007 and Projected 2012 | 131 | 1 |
| 4 Examples of Marketed OTC Products in North America (Product Name by Type and Marketer) | 135 | 1 |
| 5 North American OTC Market as a Percentage of World Market, 2007 and 2012 | 137 | 1 |
| 6 North American OTC Market Analysis, 2005-2007 | 139 | 1 |
| 7 Forecasted North American OTC Market Analysis: 2008-2012 | 140 | 1 |
| 8 North American OTC Market Analysis by Product Segment, 2005-2007 | 144 | 1 |
| 9 Forecasted North American OTC Market Analysis by Product Segment, 2008-2012 | 145 | 1 |
| 10 North American OTC Market Analysis by Selected Country, 2007 | 149 | 1 |
| 1 Population by Age for the Five Most Populated Countries in South America, Estimated 2007 | 153 | 1 |
| 2 Population by Age for the Five Most Populated Countries in South America, Projected 2012 | 154 | 1 |
| 3 Population by Gender for the Five Most Populated Countries in South America, Estimated 2007 and Projected 2012 | 156 | 1 |
| 4 Examples of Marketed OTC Products in South America (Product Name by Type and Marketer) | 160 | 1 |
| 5 South American OTC Market as a Percentage of World Market, 2007 and 2012 | 162 | 1 |
| 6 South American OTC Market Analysis, 2005-2007 | 164 | 1 |
| 7 Forecasted South American OTC Market Analysis: 2008-2012 | 165 | 1 |
| 8 South American OTC Market Analysis by Product Segment, 2005-2007 | 169 | 1 |
| 9 Forecasted South American OTC Market Analysis by Product Segment, 2008-2012 | 170 | 1 |
| 10 South American OTC Market Analysis by Selected Country, 2007 | 174 | 1 |
| 1 Total World OTC Market Analysis, 2005-2007 | 178 | 1 |
| 2 Forecasted Total World OTC Market Analysis: 2008-2012 | 179 | 1 |
| 3 Total World OTC Market Analysis by Product Segment, 2005-2007 | 183 | 1 |
| 4 Forecasted Total World OTC Market Analysis by Product Segment, 2008-2012 | 184 | 1 |
| 5 Top Ten World OTC Markets by Country, 2007 | 189 | 1 |
| 1 Leading Suppliers Shares of the OTC Market and Significant Segments of Participation, 2007 | 194 | 1 |
Graphs |
| Title | Starting Page | Number of Pages |
|---|
| Figure 1-1 Total World OTC Market Analysis: 2005-2012 | 21 | 1 |
| Figure 2-1 Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010 | 32 | 1 |
| Figure 2-2 Average Percent of Smokers Worldwide in Developed Regions | 35 | 1 |
| Figure 2-3 World Population 1980 to 2050 | 38 | 1 |
| Figure 2-4 Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Region, 2007 | 41 | 1 |
| Figure 2-5 Number of New Rx-to-OTC Switches in the United States, per Year 1976-2007 | 44 | 1 |
| Figure 2-6 Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006 | 49 | 1 |
| Figure 2-7 Gross National Income Growth by Country 2000-2005 | 52 | 1 |
| Figure 2-8 Healthcare Spending as a Percent of GDP in the United States | 54 | 1 |
| Figure 2-9 Typical Pharmacist-Consumer OTC Drug Counseling Session | 63 | 1 |
| Figure 3-1 Population for the Five Most Populated Countries in Asia-Pacific, Estimated 2007 and Projected 2012 | 72 | 1 |
| Figure 3-2 Population for Africa, Estimated 2007 and Projected 2012 | 74 | 1 |
| Figure 3-3 Population by Gender for Asia-Pacific, Estimated 2007 and Projected 2012 | 76 | 1 |
| Figure 3-4 Population by Gender for Africa, Estimated 2007 and Projected 2012 | 78 | 1 |
| Figure 3-5 Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2007 | 85 | 1 |
| Figure 3-6 Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2012 | 85 | 1 |
| Figure 3-7 Asia-Pacific/Africa OTC Market Analysis: 2005-2012 | 88 | 1 |
| Figure 3-8 Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2012 | 93 | 1 |
| Figure 3-9 Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2007 | 94 | 1 |
| Figure 3-10 Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2007 | 98 | 1 |
| Figure 4-1 Population for the Five Most Populated Countries in Europe, Estimated 2007 and Projected 2012 | 104 | 1 |
| Figure 4-2 Population by Gender for Europe, Estimated 2007 and Projected 2012 | 106 | 1 |
| Figure 4-3 European OTC Market as a Percentage of World Market, 2007 | 112 | 1 |
| Figure 4-4 European OTC Market as a Percentage of World Market, 2012 | 112 | 1 |
| Figure 4-5 European OTC Market Analysis: 2005-2012 | 115 | 1 |
| Figure 4-6 European OTC Market Analysis by Product Segment, 2005-2012 | 120 | 1 |
| Figure 4-7 European OTC Market Analysis by Product Segment, 2007 | 121 | 1 |
| Figure 4-8 European OTC Market Analysis by Selected Country, 2007 | 125 | 1 |
| Figure 5-1 Population for the Five Most Populated Countries in North America, Estimated 2007 and Projected 2012 | 130 | 1 |
| Figure 5-2 Population by Gender for North America, Estimated 2007 and Projected 2012 | 132 | 1 |
| Figure 5-3 North American OTC Market as a Percentage of World Market, 2007 | 138 | 1 |
| Figure 5-4 North American OTC Market as a Percentage of World Market, 2012 | 138 | 1 |
| Figure 5-5 North American OTC Market Analysis: 2005-2012 | 141 | 1 |
| Figure 5-6 North American OTC Market Analysis by Product Segment, 2005-2012 | 146 | 1 |
| Figure 5-7 North American OTC Market Analysis by Product Segment, 2007 | 147 | 1 |
| Figure 5-8 North American OTC Market Analysis by Selected Country, 2007 | 150 | 1 |
| Figure 6-1 Population for the Five Most Populated Countries in South America, Estimated 2007 and Projected 2012 | 155 | 1 |
| Figure 6-2 Population by Gender for South America, Estimated 2007 and Projected 2012 | 157 | 1 |
| Figure 6-3 South American OTC Market as a Percentage of World Market, 2007 | 163 | 1 |
| Figure 6-4 South American OTC Market as a Percentage of World Market, 2012 | 163 | 1 |
| Figure 6-5 South American OTC Market Analysis: 2005-2012 | 166 | 1 |
| Figure 6-6 South American OTC Market Analysis by Product Segment, 2005-2012 | 171 | 1 |
| Figure 6-7 South American OTC Market Analysis by Product Segment, 2007 | 172 | 1 |
| Figure 6-8 South American OTC Market Analysis by Selected Country, 2007 | 175 | 1 |
| Figure 7-1 Total World OTC Market Analysis: 2005-2012 | 180 | 1 |
| Figure 7-2 Total World OTC Market Analysis by Product Segment, 2005-2012 | 185 | 1 |
| Figure 7-3 Total World OTC Market Analysis by Product Segment, 2007 | 186 | 1 |
| Figure 7-4 Total World OTC Market Analysis by Product Segment, 2012 | 186 | 1 |
| Figure 7-5 Top Ten World OTC Markets by Country, 2007 | 190 | 1 |
| Figure 8-1 Leading Suppliers Shares of the OTC Market, 2007 | 195 | 1 |
